Champlain Investment Partners, LLC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 210 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Champlain Investment Partners, LLC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$93,138,879
-42.0%
2,438,829
-37.5%
0.60%
-38.8%
Q2 2023$160,477,867
-45.9%
3,901,723
-24.6%
0.99%
-47.1%
Q1 2023$296,904,943
+0.7%
5,171,659
-1.7%
1.87%
-1.2%
Q4 2022$294,901,511
+29.9%
5,259,524
-1.9%
1.89%
+22.1%
Q3 2022$227,031,000
-22.9%
5,359,555
-1.7%
1.55%
-18.6%
Q2 2022$294,616,000
-17.9%
5,452,815
-2.4%
1.90%
+2.4%
Q1 2022$358,939,000
-5.9%
5,585,730
-1.9%
1.86%
+7.6%
Q4 2021$381,497,000
-2.7%
5,694,837
-0.6%
1.73%
-8.0%
Q3 2021$392,201,000
-11.7%
5,727,237
-12.0%
1.88%
-11.1%
Q2 2021$444,244,000
-1.5%
6,510,030
-0.3%
2.11%
-10.0%
Q1 2021$451,101,000
+7.6%
6,529,175
+1.1%
2.35%
-2.5%
Q4 2020$419,284,000
+41.6%
6,458,465
+3.0%
2.41%
+19.5%
Q3 2020$296,118,000
+1.5%
6,271,020
+1.0%
2.01%
-3.8%
Q2 2020$291,719,000
+5.3%
6,208,110
+0.1%
2.09%
-16.0%
Q1 2020$276,919,000
-21.7%
6,199,220
+2.2%
2.49%
-3.5%
Q4 2019$353,565,000
+3.6%
6,066,660
+6.8%
2.58%
-7.9%
Q3 2019$341,123,000
+6.0%
5,678,760
-1.4%
2.81%
+4.0%
Q2 2019$321,709,000
+5.5%
5,760,230
+5.2%
2.70%
+1.5%
Q1 2019$305,001,000
+25.3%
5,473,820
+1.4%
2.66%
+7.6%
Q4 2018$243,358,000
-30.8%
5,395,975
+1.0%
2.47%
-20.8%
Q3 2018$351,916,000
+6.5%
5,342,585
+4.1%
3.12%
-2.4%
Q2 2018$330,518,000
+19.5%
5,131,470
+2.7%
3.20%
+7.0%
Q1 2018$276,567,000
+24.4%
4,997,595
+7.6%
2.99%
+18.8%
Q4 2017$222,361,000
-2.9%
4,646,075
+2.4%
2.52%
-6.9%
Q3 2017$228,963,000
-5.6%
4,535,720
+2.0%
2.70%
-8.8%
Q2 2017$242,444,000
+29.6%
4,447,689
+0.2%
2.96%
+20.5%
Q1 2017$187,005,000
+10.6%
4,438,760
+125.2%
2.46%
+5.0%
Q4 2016$169,059,000
+25.8%
1,970,615
+21.1%
2.34%
+14.8%
Q3 2016$134,358,000
+2.5%
1,627,599
-1.0%
2.04%
-9.7%
Q2 2016$131,104,000
+29.8%
1,643,325
+9.6%
2.26%
+23.4%
Q1 2016$101,000,000
+0.6%
1,499,400
+1.2%
1.83%
+6.7%
Q4 2015$100,441,000
+10.3%
1,481,875
-3.1%
1.72%
+7.9%
Q3 2015$91,066,000
-5.0%
1,529,240
+7.5%
1.59%
+5.0%
Q2 2015$95,880,000
+8.4%
1,423,185
-0.8%
1.51%
+0.3%
Q1 2015$88,454,000
+12.9%
1,434,775
-0.7%
1.51%
+21.1%
Q4 2014$78,364,000
+15.8%
1,445,025
+6.0%
1.25%
+6.1%
Q3 2014$67,657,000
+3.3%
1,362,945
-2.1%
1.17%
+9.3%
Q2 2014$65,519,000
+3.5%
1,392,245
+1.2%
1.07%
-1.4%
Q1 2014$63,292,000
-4.8%
1,376,215
-1.2%
1.09%
-7.1%
Q4 2013$66,478,000
+14.6%
1,393,380
-3.4%
1.17%
+6.4%
Q3 2013$58,033,000
+10.2%
1,441,825
+0.3%
1.10%
+3.6%
Q2 2013$52,680,000
+2.4%
1,438,165
+9.1%
1.06%
-2.9%
Q1 2013$51,430,0001,318,3851.10%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q2 2016
NameSharesValueWeighting ↓
VeriStar Capital Management LP 268,000$10,234,9208.72%
Madison Avenue Partners, LP 964,667$36,840,6335.23%
Pavadi Capital LLC 99,999$3,818,9624.97%
KESTREL INVESTMENT MANAGEMENT CORP 122,450$4,6762.96%
Sapience Investments, LLC 245,700$9,383,2832.26%
Ellsworth Advisors, LLC 102,500$3,882,7001.38%
Point72 Europe (London) LLP 464,462$17,737,8041.09%
COOKE & BIELER LP 2,714,194$103,655,0691.01%
TANDEM CAPITAL MANAGEMENT CORP /ADV 75,586$2,886,6300.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,827$43,033,5230.95%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders